Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
6.76
+0.12 (1.73%)
Nov 5, 2024, 3:54 PM EST - Market open
Recursion Pharmaceuticals Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$9.40
Upside
+39.16%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $16 → $11 | Strong Buy | Maintains | $16 → $11 | +62.84% | Sep 4, 2024 |
| Jefferies | Jefferies | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | -11.18% | Sep 3, 2024 |
| Leerink Partners | Leerink Partners | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +18.43% | Sep 3, 2024 |
| Needham | Needham | Strong Buy Maintains $17 → $16 | Strong Buy | Maintains | $17 → $16 | +136.86% | Aug 9, 2024 |
| Keybanc | Keybanc | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +77.65% | Jul 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +151.67% | Jun 25, 2024 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +151.67% | May 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +151.67% | Apr 9, 2024 |
| Keybanc | Keybanc | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +136.86% | Mar 4, 2024 |
| Needham | Needham | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +151.67% | Feb 28, 2024 |
| TD Cowen | TD Cowen | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jan 26, 2024 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +122.06% | Jan 17, 2024 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +122.06% | Jan 16, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | +48.04% | Nov 13, 2023 |
| Needham | Needham | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +122.06% | Nov 9, 2023 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +151.67% | Sep 5, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.